ChemoStart, the open innovation initiative led by Insud Pharma, launches its ninth edition, consolidating its international reach for the second consecutive year. The program, entirely philanthropic and with no equity requirements, is aimed at innovative startups in biotechnology and human health, offering personalized support to address development and scaling challenges.
Alhambra Venture plays a key role as a platform for visibility and connection within the Southern European entrepreneurial ecosystem. They encourage startups to learn about and participate in this new edition of the program.
ChemoStart is not a traditional accelerator. It is a flexible and adaptive initiative that evaluates the specific situation of each selected project to provide tailored support. This can include access to the group’s internal infrastructure and capabilities, as well as introductions to its global network of experts, collaborators, and strategic partners.
All of this is done in a non-intrusive and non-profit manner, as no equity participation is requested from the supported startups.
Interested startups can submit their applications through the following link:
In addition, Insud Pharma is promoting the program through its network of contacts and social media, particularly LinkedIn, where all program updates will be shared. At Alhambra Venture, we join this dissemination effort and encourage our community to share and amplify this opportunity for entrepreneurs in the health sector.
cloud technology axon
JG Ingenieros and Incosa, whose majority shareholder is Waterland Priv...
